CONFERENCE ON RETROVIRUSES
AND OPPORTUNISTIC INFECTIONS

Boston, Massachusetts
March 8–11, 2020

 

Conference Dates and Location: 
March 4–7, 2019 | Seattle, Washington
Abstract Number: 
129

OBESITY IS INDEPENDENTLY ASSOCIATED WITH NEUROCOGNITIVE DECLINE IN HIV

Author(s): 

Jeremiah Perez1, Adriana Andrade2, Ronald J. Ellis3, Mary Clare Masters4, Karl Goodkin5, Susan L. Koletar6, Frank J. Palella4, Kevin Robertson7, Ned Sacktor8, Katherine Tassiopoulos1, Kristine M. Erlandson9

1Harvard University, Boston, MA, USA,2DAIDS, NIAID, Rockville, MD, USA,3University of California San Diego, San Diego, CA, USA,4Northwestern University, Chicago, IL, USA,5East Tennessee State University, Johnson City, TN, USA,6The Ohio State University, Columbus, OH, USA,7University of North Carolina at Chapel Hill, Chapel Hill, NC, USA,8Johns Hopkins Hospital, Baltimore, MD, USA,9University of Colorado, Aurora, CO, USA

Abstract Body: 

Neurocognition may decline more with age among people living with HIV (PLWH) compared to uninfected persons. The factors related to this decline are not well understood in the current antiretroviral therapy (ART) era.

 

AIDS Clinical Trials Group (ACTG) A5322 (HAILO) is an observational cohort study of PLWH ≥ 40 years old, on ART. Participants undergo annual assessments for neurocognitive impairment (NCI), with NCI defined by ≥1 z-score ≥2 SD below 0 or ≥2 z-scores ≥1 SD below 0 on Trailmaking A and B and the Wechsler Adult Intelligence Scale-Revised Digit Symbol tests. Obesity was defined as body mass index (BMI) >30 kg/m², overweight as 25-30 kg/m², normal weight as 18.5-25 kg/m², and underweight < 18.5 kg/m². Participants who developed NCI during the first 3 years were compared to persons who maintained normal neurocognition. We used logistic regression to assess the age-adjusted associations between NCI and baseline covariates including sex, race, alcohol use, BMI, waist circumference, nadir CD4, history of AIDS defining illness, hemoglobin A1C. Only covariates with a p-value < 0.1 from age-adjusted analysis were included in the multivariable models.

 

Of 929 participants, 81% were male, 31% Black, and 20% Hispanic. Median age was 51 years (IQR 46-56). Most individuals (92%) had undetectable plasma HIV RNA with median CD4 count 631 cells/mm³ (IQR 458-840) at study entry. At study entry, 16% had NCI, 29% were obese, and 40% were overweight. Over 3 years, 6% of participants developed NCI while 78% remained unimpaired. In multivariable models, increasing age (OR 1.04; 95% CI 1.00, 1.08; p=0.04), and having an obese (OR 2.45; 1.05, 5.70; p=0.04) or overweight BMI (OR 2.21; 1.00, 4.91; p=0.05) vs normal BMI were associated with increasing prevalence of NCI compared to those who remained unimpaired.

 

Both greater age and obesity were independently associated with worsening cognitive function. These results extend previous work demonstrating a higher risk of NCI among obese PLWH by showing that obese individuals are also at greater risk of subsequently transitioning from unimpaired to impaired neurocognition.

 

Session Number: 
O-11
Session Title: 
SUPPRESSIVE ART AND THE CNS: SWITCHES, OUTCOMES, AND BIOMARKERS
Presenting Author: 
Kristine Erlandson
Presenter Institution: 
University of Colorado